Clariane Announces Medium-Term Strategic Plan and €1.5 Billion Refinancing

Clariane (CLARIA.PA) has presented its strategic plan for 2023-2026, aimed at bolstering its financial structure with a €1.5 billion refinancing plan. This includes a proposed capital increase of around €328 million to be approved at the Annual Shareholder Meeting on June 10.

The plan forecasts an annual organic growth of 5% and an EBITDA margin increase of 100 to 150 basis points by 2026. Financial leverage is expected to be less than 3x with an LTV of 55% by the end of 2025. The company also reaffirmed its ESG commitments.

CEO Sophie Boissard emphasized the resilience and adaptability of Clariane, pointing to the support from employees and stakeholders despite challenges like the Covid-19 pandemic and sectoral turbulence.

Key initiatives include personalized care solutions, skills development, and digitalization of key processes. Clariane has set ambitious ESG targets, including reducing the lost-time injury frequency rate to 29 and maintaining a Net Promoter Score above 40.